JP2020513780A5 - - Google Patents

Download PDF

Info

Publication number
JP2020513780A5
JP2020513780A5 JP2019538207A JP2019538207A JP2020513780A5 JP 2020513780 A5 JP2020513780 A5 JP 2020513780A5 JP 2019538207 A JP2019538207 A JP 2019538207A JP 2019538207 A JP2019538207 A JP 2019538207A JP 2020513780 A5 JP2020513780 A5 JP 2020513780A5
Authority
JP
Japan
Prior art keywords
strain
use according
probiotic
probiotic lactobacillus
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019538207A
Other languages
English (en)
Japanese (ja)
Other versions
JP7089523B2 (ja
JP2020513780A (ja
Filing date
Publication date
Priority claimed from GBGB1700542.2A external-priority patent/GB201700542D0/en
Priority claimed from GBGB1709731.2A external-priority patent/GB201709731D0/en
Application filed filed Critical
Priority claimed from PCT/EP2018/050789 external-priority patent/WO2018130667A1/en
Publication of JP2020513780A publication Critical patent/JP2020513780A/ja
Publication of JP2020513780A5 publication Critical patent/JP2020513780A5/ja
Application granted granted Critical
Publication of JP7089523B2 publication Critical patent/JP7089523B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019538207A 2017-01-12 2018-01-12 プロバイオティクス組成物およびその使用 Active JP7089523B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1700542.2 2017-01-12
GBGB1700542.2A GB201700542D0 (en) 2017-01-12 2017-01-12 Probiotic compositions and uses thereof
GBGB1709731.2A GB201709731D0 (en) 2017-06-19 2017-06-19 Probiotic compositions and uses thereof
GB1709731.2 2017-06-19
PCT/EP2018/050789 WO2018130667A1 (en) 2017-01-12 2018-01-12 Probiotic compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2020513780A JP2020513780A (ja) 2020-05-21
JP2020513780A5 true JP2020513780A5 (enExample) 2021-02-25
JP7089523B2 JP7089523B2 (ja) 2022-06-22

Family

ID=61386800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019538207A Active JP7089523B2 (ja) 2017-01-12 2018-01-12 プロバイオティクス組成物およびその使用

Country Status (14)

Country Link
US (1) US11166993B2 (enExample)
EP (1) EP3568144B1 (enExample)
JP (1) JP7089523B2 (enExample)
KR (1) KR102500496B1 (enExample)
CN (1) CN110177561B (enExample)
AU (1) AU2018207946B2 (enExample)
BR (1) BR112019014418A2 (enExample)
CA (1) CA3049624A1 (enExample)
CL (1) CL2019001938A1 (enExample)
MX (1) MX2019008292A (enExample)
MY (1) MY195253A (enExample)
PH (1) PH12019501629A1 (enExample)
RU (1) RU2763311C2 (enExample)
WO (1) WO2018130667A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020013439A (es) * 2018-06-18 2021-05-12 Probi Ab Composiciones probioticas y usos de las mismas.
IT201900014550A1 (it) * 2019-08-09 2021-02-09 Abiogen Pharma Spa Uso di colecalciferolo come agente attivo nel trattamento della celiachia
CN116869141A (zh) * 2022-05-05 2023-10-13 内蒙古一康健康发展有限责任公司 一种具有保健功能的益生菌复合物及其制备方法
KR102845919B1 (ko) * 2023-02-28 2025-08-14 주식회사 피엘비앤비 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물
CN119279210A (zh) * 2024-12-16 2025-01-10 山东健源生物科技有限公司 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ZA200802934B (en) * 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
EP1951273B1 (en) 2005-10-06 2014-02-12 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
PL1996696T3 (pl) 2006-03-17 2017-08-31 Probi Aktiebolag Termostabilne szczepy Lactobacillus
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
PT2367561E (pt) 2008-11-30 2015-10-23 Immusant Inc Composições e métodos para o tratamento da doença celíaca
EP2581461B1 (en) * 2011-10-14 2014-09-24 GenMont Biotech Incorporation Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases
RU2654705C2 (ru) * 2012-06-18 2018-05-22 Г.Дж. Хайнц Компани Брэндс ЛЛК Глютенозависимые расстройства
AU2014250113B2 (en) * 2013-04-03 2017-03-30 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
WO2016083450A2 (en) * 2014-11-25 2016-06-02 Stichting Top Institute Food And Nutrition New probiotic and new biomarker

Similar Documents

Publication Publication Date Title
JP2020513780A5 (enExample)
JP2004524836A5 (enExample)
Sood et al. The probiotic preparation, VSL# 3 induces remission in patients with mild-to-moderately active ulcerative colitis
Khalighi et al. Probiotics: A Comprehensive Review of Their
JP6046129B2 (ja) ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法
Chatterjee et al. Probiotics in periodontal health and disease
RU2009139657A (ru) Снижение риска диареи
CA2434337A1 (en) Combination of probiotics
RU2018139655A (ru) Бифидобактерии для увеличения безжировой массы тела
TW201636034A (zh) 細菌組成物
JP2016537410A5 (enExample)
JP2015525566A5 (enExample)
CN104366486A (zh) 五联益生菌咀嚼片的配方及制备方法
RU2019121145A (ru) Пробиотические композиции и их применение
CN108541951A (zh) 一种预防老年痴呆、增强记忆力的合生元组合物及其制剂
Nagpal et al. Probiotics, prebiotics and synbiotics: An introduction
JP2018535940A5 (enExample)
JP2018531598A5 (enExample)
JP2022056521A (ja) 免疫機能向上用組成物
GB2623930A (en) Probiotic compositions for treating and preventing colorectal cancer
WO2012067482A3 (es) COMPOSICIÓN FARMACÉUTICA ADAPTADA PARA ADMINISTRARSE ORALMENTE Y PROCESO PARA SU PREPARACIÓN, PARA PREVENCIÓN Y TRATAMIENTO DEL SÍNDROME DE INTESTINO IRRITABLE, A BASE DE UN MODIFICADOR DE LA MOTILIDAD INTESTINAL Y α-D-GALAGTOSIDASA
JP2017186330A (ja) 止瀉剤組成物
Tafla et al. Exploring the Potential of Biotics in Cancer Prevention and Treatment—Mechanisms, Experimental, and Clinical Insights.
Narnoliya et al. Synbiotics: Necessity of today’s meal
Steyn A matter of the gut